← All Evolus, INC filings

Evolus, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
EOLS
Evolus, INC
10-K: Evolus Reports 2025 Net Loss Amidst Product Launches
Evolus, a global performance beauty company, reported a net loss of $51.6 million for 2025, an increase from $50.4 million in 2024, despite an 11.6% revenue growth driven by Jeuveau sales and the U.S. launch of Evolysse Form and Smooth.
NASDAQ
EOLS
Evolus, INC
10-K: Evolus Reports Increased Revenue in 2024, Eyes Evolysse Launch in 2025
Evolus reports a 32% increase in net revenues for 2024, driven by higher sales volumes of Jeuveau, and anticipates launching Evolysse products in 2025.
NASDAQ
EOLS
Evolus, INC
10-K: Evolus, Inc. Outlines Capital Structure and Shareholder Rights in 10-K Filing
Evolus, Inc.'s 10-K filing details the company's authorized capital stock, shareholder rights, and anti-takeover provisions.